Psoriasis Treatment Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

 

Psoriasis Treatment Market

Unusual skin patches define the non-communicable autoimmune disease psoriasis. These red, scaly, itchy skin lesions can be localised or spread throughout the body. The Koebner phenomenon, which occurs when skin injury results in psoriatic skin changes, may occur there.

Several treatments can aid in symptom management, spurring the market for psoriasis treatments to expand. These therapeutic approaches include the administration of steroids, vitamin D3, ultraviolet B (UVB) light exposure, and immunosuppressive drugs like methotrexate. Creams alone can effectively treat about 75% of cases. Treatment options for mild-to-moderate psoriasis include calcipotriol, corticosteroid creams, and ointments. But when the condition worsens, oral drugs like methotrexate, acitretin, and cyclosporin are combined with creams.

The psoriasis treatment market is growing thanks to topical medications like corticosteroids, vitamin D, hydroxyanthrone, and retinoid. Mild-to-moderate psoriasis is frequently treated with topical corticosteroids. For treating large patches of damaged skin and sensitive areas like the face or skin folds, low-potency corticosteroid ointments are advised. To treat psoriasis patches on the scalp, there are medicated foams and scalp treatments on the market. Synthetic versions of vitamin D called vitamin D analogues inhibit the growth of skin cells.

A cream or solution called calcipotriene (Dovonex), which contains an analogue of vitamin D, is used alone or in conjunction with other topical medications to treat mild-to-moderate psoriasis. Hydroxanthine, also known as anthralin, is used to restore normal DNA activity in skin cells. The skin can become smoother by removing scale with anthralin (Dritho-Scalp). Topical retinoids reduce inflammation and restore normal DNA activity in skin cells.